期刊
CLINICAL IMAGING
卷 42, 期 -, 页码 193-197出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.clinimag.2016.12.011
关键词
Contrast-enhanced spectral mammography; Contrast-enhanced breast magnetic resonance; imaging; Breast cancer; High-risk screening
资金
- Beth Israel Deaconess Medical Center Department of Radiology
- Harvard Catalyst \ The Harvard Clinical and Translational Science Center (National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health) [UL1 TR001102]
- Harvard University and its affiliated academic healthcare centers
y Purpose: Our study evaluates patient preferences toward screening CESM versus MRI. Materials and methods: As part of a prospective study, high-risk patients had breast MRI and CESM. Patients completed an anonymous survey to evaluate preferences regarding the two modalities. Results: 88% of participants completed the survey. 79% preferred CESM over MRI if the exams had equal sensitivity. 89% would be comfortable receiving contrast as part of an annual screening test. Conclusion: High-risk populations may accept CESM as a screening exam and may prefer it over screening MRI if ongoing trials demonstrate screening CESM to be clinically non-inferior MRI. (C) 2016 Elsevier Inc. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据